Folic acid (FA) is an important vitamin for human growth, especially for pregnant women. FA deficiency is associated with megaloblastic anemia, neural tube defects, cardiovascular diseases, irritability, diarrhea, and psychiatric disorders. Normally, FA molecules bind to folate-binding protein (FBP) in the serum as complex. Before quantify the FA concentration, a releasing procedure should be conducted. Alkaline condition and tris(2-carboxyethyl)phosphine (TCEP) are used to release binding FA to freeing state. In this work, a chemiluminescence immunoassay (CLIA) for human serum FA was established by competition model. Streptavidin (SA) was labeled to magnetic beads by an 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide/Nhydroxysuccinimide (EDAC/NHS) method. Activated biotin molecules were labeled to FBP molecules purified from milk. FA was labeled to horseradish peroxidase (HRP) by EDAC to activate the FA molecules. e pretreated samples or standards were added into the reaction tube with biotin-FBP and FA-horseradish peroxidase (HRP), FA in the sample compete with FA-HRP for binding to biotin-FBP, the signal is inversely proportional to the FA concentration.
Introduction
Folate is the generic term for all B-vitamins that exhibit vitamin activity similar to that of folic acid.
e various compounds of this class are designated as "folates". Folic acid is the most oxidised and most stable form of folate. It is an organic compound necessary for the maintenance of normal body processes, synthesis of proteins and nucleic acids, metabolism of amino acids [1, 2] , and division of cells.
Folate deficiency is associated with megaloblastic anemia, neural tube defects, cardiovascular diseases, irritability, diarrhea, and psychiatric disorders [3] [4] [5] [6] [7] . In pregnant women, it may result in neural tube defects, developmental retardation, and early spontaneous abortion [8, 9] . erefore, in vitro diagnostic of FA is particularly important. e most common conventional methods for the analysis of FA is microbiological method and radiological immunoassay which are time consuming, labor intensive, or harmful to the environment and human health. Highperformance liquid chromatography spectrometry is accurate for FA detection and can be used for the simultaneous detection of several vitamins [10] . However, this method is quite expensive and time consuming.
e CLIA is a simple, sensitive, and cheap method for the high-throughput quantification of analyses in samples [11] . It is widely used nowadays. In this study, a direct competitive immunoassay was developed for the detection of serum FA while FBP is extracted from cow's milk and the best FA/HRP ratio conjugates was prepared. FBP are proteins that specifically bind to folate, typically the folate receptors [12] , as the most important and widely used material during the in vivo diagnostic. Its specificity and cross reactivity directly influence the performance of the method developed. FA-HRP conjugate is also one of the most important materials in the immunoassay, different FA/HRP ratio conjugates express different compete abilities. 
Materials and Methods

Reagents and
Streptavidin-Coated Magnetic Beads Preparation.
We washed the carboxylic acid beads twice with 25 mM MES, pH 6.0 buffer. We added EDAC and NHS solutions to the washed Dynabeads. It was mixed well and incubated with slow tilt rotation at room temperature for 30 min. We also washed the beads twice to remove the supernatant. e required amount of streptavidin was added into the activated magnetic beads and incubated for 30 min at room temperature with slow tilt rotation. We washed the beads twice again and then suspended the beads to 1 mg/mL with a PBS buffer containing 0.5% BSA, 0.05% polysorbate 20, and 0.02% sodium azide.
FBP Isolation and Biotinylated Conjugate Preparation
2.3.1. Isolation. FBP was isolated from fresh milk by affinity chromatography using EAH-Sepharose 4B [13] . Folic acid was coupled to the matrix. e pH of the pretreated fresh milk which was centrifuged was lowered to 3.0 by slowly adding 5 M HCl under agitation to dissociate the bounded folate from FBP. e sepharose gel was added to the solution above, and the pH was increased to 7.0 by slowly adding 5 M NaOH. After hours of agitation, the sepharose gel was washed on a glass filter with deionized water until a clear elute was obtained. en the gel was packed into a column and connected to Akta system. e impurity was washed with 0. 
Development and Optimization of the CLIA Method.
Normally, FA molecules bind to FBP in the serum as complex. Before quantifying the FA concentration, a releasing procedure should be conducted. Alkaline condition and TCEP are commonly used because of its low toxicity and odorless property compared to β-mercaptoethanol. e essential reagents required for the immunoassay include biotin-FBP, enzyme-FA conjugates, and FA. Upon mixing the biotin-FBP with a serum pretreated containing free FA, a reaction results between the FBP and FA. A simultaneous reaction between the biotin-FBP attached to the SA immobilized on the magnetic beads. e enzyme activity is inversely proportional to the FA concentration. By utilizing several different serum references of known antigen concentration, a dose response curve can be generated, and the FA concentration of an unknown can be ascertained. In this study, factors such as FA releasing procedure, FBP concentration, FA-HRP type and concentration, and incubation time were optimized.
Method Performance
2.6.1. Limitation of Detection. 20 "zero" standard are detected, and the MEAN-3SD value is calculated, and the corresponding concentration is the limitation of detection.
Precision and Recovery.
ree serum samples of different FA concentrations were tested and duplicated separately in one experiment and repeated in 20 days, and the intra-assay and interassay CV are calculated. e concentration of FA solutions was added to three serum samples of different FA concentrations, and the recovery rate is calculated. e specificity of the FBP used to selected substances was evaluated by adding the interfering substance to a serum matrix at various concentrations. e cross reactivity (CR) is defined at the point where the reduction in signal corresponds to 50% of the signal achieved in the absence of analyte (B/B0 of 50%), as a percentage of the analyte concentration given the same fall in signal. e CR values were calculated as follows [14] :
2.6.4. Accelerated Stability. e whole kit including SAmagnetic bead, biotin-FBP, FA-HRP, and FA standards was incubated at 37°C for 7 days compared the signals of standards and concentration of controls at different days.
Methodology Comparison.
e CLIA method was compared with a reference chemiluminescence immunoassay method of Beckman Coulter. Biological specimens were used with values that ranged from 1.1 ng/ml-23.9 ng/ml. e total number of such specimens is 240.
Results
Characterization of SA-Coated Magnetic Beads.
Add 30 μL SA-coated magnetic beads prepared and 50 μL biotin-HRP (50 ng/mL) into a reaction tube incubated for 30 min at 37°C and wash the beads 3 times with washing buffer. en add 100 μL signal reagent to detect the signals. e RLUs result is 803,394 which indicates that the SA is successfully labeled onto the surface of the magnetic beads.
e SA labeled beads showed only a little aggregation compared to unlabeled beads. e microphotographs are shown in Figure 1 .
Characterization of FBP and Biotin-FBP Conjugates.
e purified FBP was coated on the surface of the microwells. Add 50 μL FA-HRP conjugates (0.5 μg/mL) prepared in our lab, incubated for 30 min at 37°C, and wash the wells 5 times with washing buffer. en add 100 μL signal reagent to detect the signals. e RLUs result is 249,403 indicates that the purified FBP have good biological activity. To estimate biotin incorporation, a solution containing the biotinylated FBP is added to a mixture of HABA and avidin solution purchased from Sigma.
e biotin/FBP mole ratio is approximately 6.3 calculated by the method descript in the kit manual.
Characterization of FA-HRP Conjugates.
Purchased FBP from Scripps coated microplates were prepared to verify whether FA is labeled to HRP molecules successfully. Add 50 μL different FA-HRP conjugates (1.0 μg/mL) with HRP as the control into the FBP coated wells; then incubate for 30 min at 37°C, and wash the plate 5 times with washing buffer. en add 100 μL signal reagent. e results indicate that FA was successfully labeled to HRP. See the results in Figure 2 . Figure 3 . A series concentration of biotin-FBP and FA-HRP were investigated, the signals and Signal (0 ng/mL)/Signal (25 ng/mL) value is acceptable when biotin-FBP concentration is 520 ng/mL and FA-HRP concentration is 500 ng/mL. e optimization results are shown in Table 1 .
Development of the CLIA Method
3.4.1. Method Procedure. Add peptide 30 μL serum and 10 μL stabilizer reagent which is used to stabilize the folate in the sample into the reacting tube. en add 20 μL alkaline solution called releasing reagent into the tube. After a 10 min incubation to release the folate from FBP completely, decrease the pH to neutral with an acid solution called neutralization buffer. Add peptide 50 μL FBP-Biotin into the tube and hold for 20 min, then add 50 μL FA-HRP conjugated, and incubate for 5 min. Add 30 μL magnetic bead coated with SA and incubate for another 5 min. Lastly, the magnetic bead was washed three times with washing buffer, and then add 200 μL signal reagent. e reader will give the signal values. All the incubation temperature should be controlled at 37°C.
Optimization of Biotin-FBP and FA-HRP
Optimization of Incubation Time.
e biotin-FBP and FA-HRP incubation time is studied, respectively. e procedure remains unchanged described in method procedure except the incubation time. e signals increase as the incubation time is lengthened at first, but remain constant while the reaction achieves dynamic equilibrium. For clinical request for saving time, we choose 20 min incubation of biotin-FBP and 5 min incubation of FA-HRP as the best incubation condition which achieve high signals with a relative low variable coefficient. e signal results are shown in Figure 4 and Table 2 .
Folic Acid Releasing Procedure Optimization.
Alkaline condition and TCEP are used in this study to release the binding FA to freeing state. e more alkaline the releasing solution, the more the FA released. According to the results, 1.2 M sodium hydroxide-releasing solution incubated with samples for 15 min at 37°C seems releasing FA completely but with unacceptable CV values. See the results in Figure 5 . When adding TCEP into the stabilizing solution, CV values decrease to an acceptable level. However, when adding excessive TCEP higher than 0.2%, it may reduce the activity of HRP conjugates or biotin-FBP, the signals of standards and samples decrease. e results are shown in Figure 6 . erefore, 1.2 M sodium hydroxide-releasing solution and 0.2% TCEP are chosen as the important releasing agents. Further studies were conducted to optimize the releasing time, and 15 min is the best for accuracy and precision did not get better while extension the releasing time, and the results are shown in Figure 7 .
Method Performance.
e standard curve of signal against FA concentration have a regression correlation coefficient (R 2 ) of 0.999 by 4-parameter logistic function curve fitting, the equation is Y � 440081.9 + (−476203.8)/(1 + EXP(−(−2.8074 + 1.3656 * ln (X)))). e LOD is 0.44 ng/ml. e intra-assay CV is 3.6%-7.1%, and the interassay CV is 4.2%-7.5%, and the results are shown in Table 3 . e recovery rate is 92.1%-103.5%, and the results are shown in Table 4 . e developed methods have high selectivity for FA. CR values were less than 0.1% with aminopterin, folinic acid, and methotrexate. e accelerated stability studies show the kit with excellent stability. e signals of the standards and the samples at different days under 37°C incubation change no more than 10% compare to the control, see the results in Figure 8 . 
Discussion and Conclusion
According to the previous literatures, there are indeed many quantification methods for FA such as chemiluminescence reaction based on peroxomonosulfate-cobalt (II) system [15] , capillary electrophoresis system [16] , sodium hypochlorite-folic acid-emicarbazide hydrochloride system [17] , flow injection analysis system, [18] and some other methods [19, 20] . Although the LOD is as low as 6 × 10 −10 mol/L [15] , these methods are mainly used for quantification of FA in pharmaceutical preparations, juices, spinach, and human urine which need not release from its binding state as in human serum. HPLC-MS/MS [21] can be an accurate and quick method. But the cost of instruments, consumables, and the low throughput limited the wide application especially in the inspection and organizations with many samples. is study established a chemiluminescence immunoassay for the quantification of human serum FA with good performance and overall stability.
e method comparison shows that the CLIA method established has a good Releasing time 15min
Releasing time 20min Journal of Analytical Methods in Chemistrycorrelation with the imported FA kit from Beckman Coulter which is highly admitted and widely used.
For the competitive CLIA method, the material such as FA-HRP conjugates should be paid more attention as different FA-HRP incorporation show different compete ability, so the label procedure of the conjugates should be strictly controlled to minimize the batch difference. Normally, FA molecules bind to FBP in the serum as complex; the samples should be pretreated to release FA to the freeing state. In this study, 1.2 M sodium hydroxide and 0.2% TCEP were used as releasing agents to maximize the release of FA while keep a low variable coefficient.
During the development of the method, an interesting unusual phenomenon was found. After adding the substrate, the signal of the serum samples increases slowly and reaches the peak at about 1 to 8 min while the standards reach the peak at about 1 min. Mostly, the signals of the samples reach the peak at 1 min, sometimes at 5 or 8 min. us, the calculated concentration of the samples varies very much between replicates inter-or intra-assay. is phenomenon did not present in many other projects including VB12, FER, and 25-OH-Vitamin D in our lab. We assume that there are some folate isomers with reducibility which cannot be washed away to interfere the chemiluminescence reaction. So appropriate amount of potassium iodate was added in the incubation buffer to oxidize these substances and minimize the interference. Fortunately, the serum sample signals increase the same as the standards. But further studies should be conducted to investigate the deeper reason.
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